Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: A prospective study

Transfusion

Volumn 37, Issue 9, 1997, Pages 941-946

  Preiksaitis, J K ^a   Desai, S ^a   Vaudry, W ^a   Roberts, S ^a   Akabutu, J ^a   Grundy, P ^a   Wilson, B ^a   Boshkov, L ^b   Hannon, J ^c   Joffres, M ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c Canadian Red Cross Society   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; CHILD PARENT RELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; RETICULOENDOTHELIAL NEOPLASM; SEROCONVERSION; SOLID TUMOR; THROMBOCYTE TRANSFUSION; VIRUS ISOLATION;

EID: 9844229887     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37997454022.x     Document Type: Article

References (20)

1. Roberts I. Bone marrow transplantation in children: current results and controversies. Meeting, Hilton Head Island, SC, March 1994. Bone Marrow Transplant 1994;14:197-9.
2. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
3. Bowden RA, Slichter SJ, Sayers MH, et al. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991;78:246-50.
4. Miller WJ, McCullough J, Balfour HH Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991;7:227-34.
5. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
6. Sayers MH, Anderson KC, Goodnough LT, et al. Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med 1992;116:55-62.
7. Cox F, Hughes WT. The value of isolation procedures for cytomegalovirus infections in children with leukemia. Cancer 1975;36:1158-61.
8. Wilhelm JA, Matter L, Schopfer K. The risk of transmitting cytomegalovirus to patients receiving blood transfusions. J Infect Dis 1986;154:169-71.
9. Murphy MF, Grint PC, Hardiman AE, et al. Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia (letter). Br J Haematol 1988;70:253-4.
10. Preiksaitis JK, Brown L, McKenzie M. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. J Infect Dis 1988;157:523-9.
11. Lee PI, Chang MH, Hwu WL, et al. Transfusion-acquired cytomegalovirus infection in children in a hyperendemic area. J Med Virol 1992;36:49-53.
12. Hillyer CD, Snydman DR, Berkman EM. The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products. Transfusion 1990;30:659-66.
13. Lamberson HV Jr, McMillian JA, Weiner LB, et al. Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV. J Infect Dis 1988;157:820-3.
14. Krajden M, Shankaran P, Bourke C, Lau W. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology. J Clin Microbiol 1996;34:29-33.
15. Dzik WH. Mononuclear cell microchimerism and the immunomodulatory effect of transfusion. Transfusion 1994;34:1007-12.
16. Cheung KS, Lang DJ. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J Infect Dis 1977;135:841-5.
17. Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992;80:2128-35.
18. Yow MD, White NH, Taber LH, et al. Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study. J Pediatr 1987;110:37-42.
19. Stagno S, Cloud GA. Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in off-spring. Proc Natl Acad Sci U S A 1994;91:2384-9.
20. Preiksaitis JK, Larke RP, Froese GJ. Comparative seroepidemiology of cytomegalovirus infection in the Canadian Arctic and an urban center. J Med Virol 1988;24:299-307.